Hedge funds net sold US equities last week, Goldman says

Investing.com -- Hedger funds (HFs) net sold US equities last week, according to Goldman Sachs, predominantly driven by risk-on flows. Short sales were notably more frequent than long buys, with a ratio of 2 to 1.

This selling activity was largely concentrated in macro products, including indexes and exchange-traded funds (ETFs), which constituted approximately 50% of the net selling.

“A reversal from last week’s covering, US-listed ETF shorts increased by +5.6%, led by shorting in Sector, Credit, and International ETFs,” Goldman Sachs said in the report on Friday.

The shift in investor behavior resulted in net sales of single stocks for the first time in seven weeks, with short sales surpassing long buys by a ratio of 1.5 to 1.

Information Technology, Communication Services, and Materials sectors were the most sold on a notional basis. Conversely, sectors such as Health Care, and Consumer Discretionary saw net buying activity.

HFs continued to show interest in US Financials stocks, the report reveals, marking the second consecutive week of net buying in this sector.

The gross trading activity in US Financials, both in terms of long buying and short selling, has reached a significant high, ranking in the 100th percentile over a five-year lookback period. The sector's gross and net allocations as a percentage of total US exposure are now at 12.7% and 11.5%, respectively.

Health Care emerged as the most net bought US sector over the past week. According to the report, the buying activity was concentrated in Pharmaceuticals, Health Care Equipment & Supplies, and Health Care Providers & Services. This outweighed the selling seen in Biotechnology and Life Sciences Tools & Services.

“US Health Care has now been net bought in 7 of the last 8 weeks, and the sector long/short ratio now stands at 2.46, in the 92nd percentile vs. the past year and in the 46th percentile vs. the past five years,” Goldman notes.

Source: Investing.com

Останні публікації
Exclusive-Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
18.11.2024 - 13:00
US stock futures mixed; Nvidia earnings, PMI data, Fed speakers in focus
18.11.2024 - 13:00
Xiaomi shares surge on robust EV sales and revenue jump
18.11.2024 - 13:00
Spirit Airlines files for bankruptcy, plans major debt restructuring
18.11.2024 - 13:00
Nvidia's Blackwell revenue in focus as sales growth slows
18.11.2024 - 13:00
CVS jumps on report it will add to board in deal with hedge fund Glenview
18.11.2024 - 13:00
Equity market pullback could have -5% to -9% downside, Evercore says
18.11.2024 - 13:00
CVS adds four new board members in deal with Glenview Capital
18.11.2024 - 13:00
European stocks mixed; economic data, central bank speakers eyed
18.11.2024 - 13:00
Magic Software Enterprises earnings missed by $0.02, revenue topped estimates
18.11.2024 - 13:00
Liberty Energy shares surge as CEO Chris Wright named Trump's energy secretary
18.11.2024 - 12:00
India stocks lower at close of trade; Nifty 50 down 0.30%
18.11.2024 - 12:00
'Elon Premium' boosts Tesla, but also presents risk, says Barclays
18.11.2024 - 12:00
US no-frills pioneer Spirit Airlines files for bankruptcy protection
18.11.2024 - 12:00
UBS says S&P 500 returns in 2025 likely to be 'backloaded'
18.11.2024 - 12:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Як вплине завтра звіт NFP на курс долара США?